ArticleClinical & translational immunology2026
Control of poorly immunogenic tumors with systemic STING agonist-loaded liposomes targeting cross-presenting dendritic cells.
Bijun Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.